Profit Or Loss [Abstract]

Pharming Group N.V. - Filing #1883078

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
205,622,000 USD
198,871,000 USD
Cost of sales
17,562,000 USD
21,142,000 USD
Gross profit
188,060,000 USD
177,729,000 USD
Other income
14,523,000 USD
2,620,000 USD
Administrative expenses
46,016,000 USD
36,974,000 USD
Other expense, by function
184,350,000 USD
166,788,000 USD
Profit (loss) from operating activities
18,233,000 USD
13,561,000 USD
Finance income
4,485,000 USD
14,894,000 USD
Finance costs
5,463,000 USD
6,185,000 USD
Profit (loss) before tax
14,987,000 USD
23,078,000 USD
Tax expense (income)
1,313,000 USD
7,082,000 USD
Profit (loss)
USD
USD
13,674,000 USD
USD
13,674,000 USD
USD
USD
USD
15,996,000 USD
15,996,000 USD
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.021
0.025
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.019
0.023

Talk to a Data Expert

Have a question? We'll get back to you promptly.